SEC Comment Letter 0000000000-24-005003 to TRINITY BIOTECH PLC (TRIB)
TRINITY BIOTECH PLC
Date: May 2, 2024 · CIK: 0000888721 · Accession: 0000000000-24-005003
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-279017
Letter
United States securities and exchange commission logo May 2, 2024 John Gillard Chief Executive Officer Trinity Biotech plc IDA Business Park Bray, Co. Wicklow Ireland Re:Trinity Biotech plc Registration Statement on Form F-3 Filed April 30, 2024 File No. 333-279017 Dear John Gillard: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Mary Brown
Show Raw Text
United States securities and exchange commission logo
May 2, 2024
John Gillard
Chief Executive Officer
Trinity Biotech plc
IDA Business Park
Bray, Co. Wicklow
Ireland
Re:Trinity Biotech plc
Registration Statement on Form F-3
Filed April 30, 2024
File No. 333-279017
Dear John Gillard:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Mary Brown